LogoPopulis
Population Health Strategy

Your Sickest 5% Are Telling You Everything

The top 5% of your attributed lives drive 52% of total spend. Populis maps every clinical, social, and utilization signal in that cohort — and delivers the intervention playbook that bends the curve before your next payer renegotiation.

$2.1B

Avoidable spend identified across client portfolios

47

Health systems and Medicaid programs served

18 mo

Median time to measurable PMPM reduction

Scroll
01 / Operational

What happens when our largest payer shifts to full capitation next contract cycle?

$127M

Median unmanaged risk exposure for a 500-bed system entering full capitation without stratified intervention protocols

Full capitation doesn't create new risk — it makes visible the risk you've been carrying invisibly. The systems that enter capitation confidently have already mapped their attributed population by clinical complexity, social vulnerability, and historical utilization. They know which 4,200 lives will drive 60% of their cost.

Populis builds that map in 90 days using your claims, EHR, and publicly available SDOH data. We layer in our national benchmark database — 14 million attributed lives across 47 client systems — to identify where your cohort diverges from peer performance. The output is a risk-stratified intervention matrix: which patients, which interventions, which sequence, which timeline.

Before your next payer negotiation, you walk in knowing your number. Not a range. A number — defensible, auditable, and supported by the same actuarial methodology your payer is using on the other side of the table.

Spend trajectoryFull capitation active
Q1Q2Q3Q4Q5Q6
02 / Operational

How do we stratify our attributed lives when our data infrastructure is still maturing?

68%

Of actionable stratification intelligence can be derived from claims data alone — no EHR integration required to begin

The most common reason health systems delay population health work is waiting for a clean data environment. That delay is itself a cost. Every quarter without stratification is a quarter where high-risk patients cycle through the ED instead of a care management pathway.

Populis begins with what you have. Our stratification methodology is tiered: Tier 1 uses only claims — diagnosis codes, utilization patterns, pharmacy fill rates, and geographic clustering. This alone identifies your top 5% with 91% accuracy against clinical validation studies. Tier 2 adds EHR data where available. Tier 3 incorporates SDOH indices, community health worker notes, and social service utilization.

Most clients reach actionable stratification within 60 days of engagement — before any technology infrastructure changes are complete. The intervention programs run in parallel with any platform migrations you have underway.

Spend distribution by risk tier% of total spend
38%T527%T418%T311%T26%T1
03 / Strategic

Can you show us outcomes that survived a payer audit — not just internal projections?

$227

PMPM reduction achieved within 24 months across our three largest health system engagements, validated by independent actuarial review

Every health system has seen the vendor deck that shows 40% cost reduction in a cherry-picked cohort with no comparison group. We don't build those decks. Our outcomes methodology uses difference-in-differences analysis against matched control populations — the same standard CMS applies to ACO performance measurement.

Across our three largest engagements — a 1,200-bed integrated delivery network, a regional Blue Cross attributed population of 180,000 lives, and a state Medicaid managed care organization — the validated 24-month PMPM reductions ranged from $198 to $261. All three passed payer audit. All three were used as evidence in subsequent contract renegotiations.

We can provide redacted outcome reports and actuarial validation letters under NDA before you sign an engagement agreement. We believe you should see the evidence before the proposal.

PMPM cost trajectory
BaselinePost-intervention
Y1Y2Y3Y4
04 / Existential

Can a system like ours actually survive the full transition to value-based care?

83%

Of health systems that achieve value-based contract profitability share one characteristic: stratification-led care management initiated before the contract went live

The honest answer is: it depends on which 20 decisions you make in the next 36 months. The systems that fail the transition don't fail because value-based care is structurally unworkable for them — they fail because they entered contracts before they could manage the risk they accepted.

The readiness profile we build for every prospective client maps five dimensions: clinical stratification maturity, SDOH integration depth, care management capacity, network leakage rates, and data infrastructure. The gap between where you are and where you need to be is almost always smaller than it looks — but it requires a sequenced intervention plan, not a platform purchase.

We have worked with systems that entered this conversation at 35% readiness and reached contract-ready status in 18 months. We have also told three prospective clients that their timeline was unrealistic and recommended they renegotiate their contract terms before engaging us. That kind of candor is what a confidential briefing is for.

Value readiness profile
Your systemIndustry avg
Clinical StratificationSDOH IntegrationNetwork LeakageCare ManagementData Infrastructure
2026 Report

Population Health
Readiness Index

Benchmarks drawn from 47 health systems and 12 state Medicaid programs. Covers clinical stratification maturity, SDOH integration depth, care management capacity, and network leakage rates — segmented by system size and payer mix.

Download Free Report →
Populis · 2026
Population Health
Readiness Index
Clinical Stratification82%
SDOH Integration55%
Care Management78%
Data Infrastructure45%

47 health systems · 12 Medicaid programs

Next Step

The playbook already exists.
We built it for your ZIP codes.

In a 45-minute confidential briefing, we map your highest-cost cohorts against our national benchmark database and show you exactly where the spend is concentrated — before you've signed anything.

Cohort benchmark

Your top-5% compared to 47 peer systems by diagnosis, utilization, and ZIP code.

Intervention gap map

Where clinical and social interventions are absent in your highest-risk population.

PMPM reduction range

Conservative and aggressive scenarios based on your current payer mix and contract structure.

No obligationNDA available on requestCMO & VP-level only45 minutes, no sales pitch